A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection
Clinical trial NCT02723084 · COMPLETED
Trial details
- NCT number
- NCT02723084
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-08
- Primary completion
- 2017-01-19
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.